100+ 400 mg day bez235 PowerPoint (PPT) Presentations, 400 mg day bez235 PPTs

400 mg day bez235 - PowerPoint PPT Presentation

Abstract #3005

First-in-man Phase I study of the oral dual PI3K and mTORC1/2 inhibitor BEZ235 in patients with advanced solid tumors. Howard Burris 1 , Jordi Rodon 2 , Sunil Sharma 3 , Roy Herbst 4 , Josep Tabernero 2 , Jeffrey Infante 1 , Antonio Silva 5 , David Demanse 5 , Wolfgang Hackl 5 , Jose Baselga 2

★ ★ ★ ★ ★

325 views • 26 slides

View 400 mg day bez235 PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of 400 mg day bez235 PowerPoint presentations. You can view or download 400 mg day bez235 presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.

'400 mg day bez235' presentation slideshows

400 mg day bez235 - PowerPoint PPT Presentation

Abstract #3005